|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheng XJ, Lin JC and Tu SP: Etiology and
prevention of gastric cancer. Gastrointest Tumors. 3:25–36. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Compare D, Rocco A and Nardone G: Risk
factors in gastric cancer. Eur Rev Med Pharmacol Sci. 14:302–308.
2010.PubMed/NCBI
|
|
4
|
Newton AD, Datta J, Loaiza-Bonilla A,
Karakousis GC and Roses RE: Neoadjuvant therapy for gastric cancer:
Current evidence and future directions. J Gastrointest Oncol.
6:534–543. 2015.PubMed/NCBI
|
|
5
|
Otani K, Li X, Arakawa T, Chan FK and Yu
J: Epigenetic-mediated tumor suppressor genes as diagnostic or
prognostic biomarkers in gastric cancer. Expert Rev Mol Diagn.
13:445–455. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Monroig Pdel C, Chen L, Zhang S and Calin
GA: Small molecule compounds targeting miRNAs for cancer therapy.
Adv Drug Deliv Rev. 81:104–116. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lim LP, Lau NC, Garrett-Engele P, Grimson
A, Schelter JM, Castle J, Bartel DP, Linsley PS and Johnson JM:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ding X, Liu J, Liu T, Ma Z, Wen D and Zhu
J: miR-148b inhibits glycolysis in gastric cancer through targeting
SLC2A1. Cancer Med. 6:1301–1310. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bai X, Meng L, Sun H, Li Z, Zhang X and
Hua S: MicroRNA-196b inhibits cell growth and metastasis of lung
cancer cells by targeting Runx2. Cell Physiol Biochem. 43:757–767.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Karatas OF, Wang J, Shao L, Ozen M, Zhang
Y, Creighton CJ and Ittmann M: miR-33a is a tumor suppressor
microRNA that is decreased in prostate cancer. Oncotarget.
8:60243–60256. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pillai RS: MicroRNA function: Multiple
mechanisms for a tiny RNA? RNA. 11:1753–1761. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Long MJ, Wu FX, Li P, Liu M, Li X and Tang
H: MicroRNA-10a targets CHL1 and promotes cell growth, migration
and invasion in human cervical cancer cells. Cancer Lett.
324:186–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Y, Zhang H, Dong Y, Fan Y, Li Y, Zhao
C, Wang C, Liu J, Li X, Dong M, et al: MiR-146b-5p functions as a
suppressor miRNA and prognosis predictor in non-small cell lung
cancer. J Cancer. 8:1704–1716. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen Y, Zhang Z, Luo C, Chen Z and Zhou J:
MicroRNA-18b inhibits the growth of malignant melanoma via
inhibition of HIF-1α-mediated glycolysis. Oncol Rep. 36:471–479.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Y, Chen M, Liu J, Li L, Yang X, Zhao J,
Wu M and Ye M: Upregulation of microRNA-18b contributes to the
development of colorectal cancer through inhibiting CDKN2B. Mol
Cell Biol. 37(pii): e00391–17. 2017.PubMed/NCBI
|
|
17
|
Murakami Y, Tamori A, Itami S, Tanahashi
T, Toyoda H, Tanaka M, Wu W, Brojigin N, Kaneoka Y, Maeda A, et al:
The expression level of miR-18b in hepatocellular carcinoma is
associated with the grade of malignancy and prognosis. BMC Cancer.
13:992013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Q, Tan XP, Yuan YS, Hu CM, He CH,
Wang WZ, Li JC, Zhao Q and Liu NZ: Decreased expression of KLF6 and
its significance in gastric carcinoma. Med Oncol. 27:1295–1302.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sangodkar J, Shi J, DiFeo A, Schwartz R,
Bromberg R, Choudhri A, McClinch K, Hatami R, Scheer E, Kremer-Tal
S, et al: Functional role of the KLF6 tumour suppressor gene in
gastric cancer. Eur J Cancer. 45:666–676. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang X, Nie Y, Du Y, Cao J, Shen B and Li
Y: MicroRNA-181a promotes gastric cancer by negatively regulating
tumor suppressor KLF6. Tumour Biol. 33:1589–1597. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shrestha S, Hsu SD, Huang WY, Huang HY,
Chen W, Weng SL and Huang HD: A systematic review of microRNA
expression profiling studies in human gastric cancer. Cancer Med.
3:878–888. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu X, Lv M, Wang H and Guan W:
Identification of circulating microRNAs as novel potential
biomarkers for gastric cancer detection: A systematic review and
meta-analysis. Dig Dis Sci. 59:911–919. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rao M, Zhu Y, Zhou Y, Cong X and Feng L:
MicroRNA-122 inhibits proliferation and invasion in gastric cancer
by targeting CREB1. Am J Cancer Res. 7:323–333. 2017.PubMed/NCBI
|
|
25
|
Husby S, Ralfkiaer U, Garde C, Zandi R, Ek
S, Kolstad A, Jerkeman M, Laurell A, Räty R, Pedersen LB, et al:
miR-18b overexpression identifies mantle cell lymphoma patients
with poor outcome and improves the MIPI-B prognosticator. Blood.
125:2669–2677. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu X, Zhen Y, Yang H, Wang H, Zhou Y, Wang
E, Marincola FM, Mai C, Chen Y, Wei H, et al: Loss of connective
tissue growth factor as an unfavorable prognosis factor activates
miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in
nasopharyngeal carcinoma. Cell Death Dis. 4:e6342013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fonseca-Sanchéz MA, Pérez-Plasencia C,
Fernandez-Retana J, Arechaga-Ocampo E, Marchat LA, Rodríguez-Cuevas
S, Bautista-Piña V, Arellano-Anaya ZE, Flores-Pérez A, Diaz-Chávez
J and López-Camarillo C: microRNA-18b is upregulated in breast
cancer and modulates genes involved in cell migration. Oncol Rep.
30:2399–2410. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dar AA, Majid S, Rittsteuer C, de Semir D,
Bezrookove V, Tong S, Nosrati M, Sagebiel R, Miller JR III and
Kashani-Sabet M: The role of miR-18b in MDM2-p53 pathway signaling
and melanoma progression. J Natl Cancer Inst. 105:433–442. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ito G, Uchiyama M, Kondo M, Mori S, Usami
N, Maeda O, Kawabe T, Hasegawa Y, Shimokata K and Sekido Y:
Kruppel-like factor 6 is frequently down-regulated and induces
apoptosis in non-small cell lung cancer cells. Cancer Res.
64:3838–3843. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
DiFeo A, Narla G and Martignetti JA:
Emerging roles of Kruppel-like factor 6 and Kruppel-like factor 6
splice variant 1 in ovarian cancer progression and treatment. Mt
Sinai J Med. 76:557–566. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang X, Li X and Guo B: KLF6 induces
apoptosis in prostate cancer cells through up-regulation of ATF3. J
Biol Chem. 283:29795–29801. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kimmelman AC, Qiao RF, Narla G, Banno A,
Lau N, Bos PD, Nuñez Rodriguez N, Liang BC, Guha A, Martignetti JA,
et al: Suppression of glioblastoma tumorigenicity by the
Kruppel-like transcription factor KLF6. Oncogene. 23:5077–5083.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cho YG, Choi BJ, Song JW, Kim SY, Nam SW,
Lee SH, Yoo NJ, Lee JY and Park WS: Aberrant expression of
krUppel-like factor 6 protein in colorectal cancers. World J
Gastroenterol. 12:2250–2253. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gao Y, Li H, Ma X, Fan Y, Ni D, Zhang Y,
Huang Q, Liu K, Li X, Wang L, et al: KLF6 suppresses metastasis of
clear cell renal cell carcinoma via transcriptional repression of
E2F1. Cancer Res. 77:330–342. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gehrau RC, D'Astolfo DS, Andreoli V, Bocco
JL and Koritschoner NP: Differential expression of the klf6 tumor
suppressor gene upon cell damaging treatments in cancer cells.
Mutat Res. 707:15–23. 2011. View Article : Google Scholar : PubMed/NCBI
|
